ÇALIK, E. Et Al. 2018. Targeted Treatment For Cervical Cancer: A Src-tyrosin Kinase Inhibitor ‘Bosutinib’. HUMAN GENOME AND HEALTHThe First International Conference in Georgia , 23.

ÇALIK, E., HASDEMİR, P. S., ERBAYKENT TEPEDELEN, B., GÜVENAL, T., & KORKMAZ, M., (2018). Targeted Treatment For Cervical Cancer: A Src-tyrosin Kinase Inhibitor ‘Bosutinib’ . HUMAN GENOME AND HEALTHThe First International Conference in Georgia (pp.23).

ÇALIK, ESAT Et Al. "Targeted Treatment For Cervical Cancer: A Src-tyrosin Kinase Inhibitor ‘Bosutinib’," HUMAN GENOME AND HEALTHThe First International Conference in Georgia, 2018

ÇALIK, ESAT Et Al. "Targeted Treatment For Cervical Cancer: A Src-tyrosin Kinase Inhibitor ‘Bosutinib’." HUMAN GENOME AND HEALTHThe First International Conference in Georgia , pp.23, 2018

ÇALIK, E. Et Al. (2018) . "Targeted Treatment For Cervical Cancer: A Src-tyrosin Kinase Inhibitor ‘Bosutinib’." HUMAN GENOME AND HEALTHThe First International Conference in Georgia , p.23.

@conferencepaper{conferencepaper, author={ESAT ÇALIK Et Al. }, title={Targeted Treatment For Cervical Cancer: A Src-tyrosin Kinase Inhibitor ‘Bosutinib’}, congress name={HUMAN GENOME AND HEALTHThe First International Conference in Georgia}, city={}, country={}, year={2018}, pages={23} }